González-Chon O, Acosta-Garduño F, Marrón PM, Mille LJE, Cisneros RFJ

Idioma: Español
Referencias bibliográficas: 15
Paginas: 35-39
Archivo PDF: 190.67 Kb.

FRAGMENTO

Valoración y manejo cardiovascular en cirugía no cardíaca

La justificación del por qué conocer las guías de valoración del paciente cardiópata en cirugía no cardíaca va en función de la magnitud del problema, ya que se calcula que aproximadamente cada año, cuando menos en la unión europea, se presentan 167,000 complicaciones en cirugía no cardíaca, las cuales tienen como consecuencia 19,000 muertes

REFERENCIAS (EN ESTE ARTÍCULO)

1. Kristensen SD, Knuuti J, Saraste A, Anker S, Botker HE, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. European Heart Journal. 2014;35:2383-2431.

2. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, et al. 2014 ACC/AHA Guideline on perioperative Cardiovascular evaluation and management of patients undergoing noncardiac-surgery. J Am Coll Cardiol. 2014;64:77-137.

3. Wirthlin DJ, Cambria RP. Surgery-specific considerations in the cardiac patient undergoing noncardiac surgery. Prog Cardiovasc Dis. 1998;40:453-468.

4. Glance LG, Lustik SJ, Hannan EL, Osler TM, Mukamel DB, Qiat F, et al. The surgical mortality probability model: derivation and validation of a simple risk prediction rule for noncardiac surgery. Ann Surg. 2012;255:696-702.

5. Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, et al. Exercise standards for testing and training: A statment for healthcare professionals from the American Heart Association. Circulation. 2001;104:1694-1740.

6. Bilimoria KY, Liu Y, Paruch JL, et al. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. 2013;217:833-842.

7. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for predicition of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043-1049.

8. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33:2551-2567.

9. Rohde LE, Polanczyk CA, Goldman L, Cook EF, Lee RT, Lee TH. Usefulness of transthoracic echocardiography as a tool for risk stratification of patients undergoing major noncardiac surgery. Am J Cardiol. 2001;87:505-509.

10. Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D et al. Stress echocardiography expert consensus statement: executive summary: European Association of Echocardiography. Eur Heart J. 2009;30:278-289.

11. Juul AB, Grp DT. Effect of peri-operative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomized placebo controlled, blinded multicentre trial. BMJ. 2006;332:1482.

12. Alonso-Coello P, Paniagua P, Mizera R, Devereaux PJ. Should physicians initiate beta-blocker therapy in patients undergoing non-cardiac surgery? Insights from the POISE trial. Pol Arch Med Wewn. 2008;118:616-618.

13. Hindler K, Shaw AD, Samuels J, Fulton S, Collard CD, Riedel B. Improved post-operative outcomes associated with pre-operative statin therapy. Anesthesiology. 2006;105:1260-1272, quiz 1289-1290.

14. Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention: cardiovascular risk after its perioperative withdrawal versus bleeding risk with its continuation-review and meta-analysis. J Int Med. 2005;257:399-414.

15. Devereaux PJ, Mrkobrada M, Sessler DI, Leslie K, Alonso-Coello P, Kurz A et al. Aspirin in patients undergoing noncardiac surgery. N Eng J Med. 2014;370: 1494-1503.